Full spectrum allergic rhinitis symptom relief (in a single device)
Dymista® treats all symptoms of seasonal and perennial allergies more effectively than any other single pharmacotherapy
Dymista® leads to greater symptom improvement than using either azelastine or fluticasone propionate alone.1
Dymista® provides substantial symptom relief from all symptoms of allergic rhinitis1 in a single device. This Is important as many allergic rhinitis patients continue to experience symptoms, even those taking treatments.2 In a survey of 1000 patients with seasonal allergic rhinitis in the UK, 70.5% of those with moderate/severe symptoms were taking at least two allergic rhinitis medications.3
The only combination of INS and INAH available in a singular device
Click below to hear what the experts say about the symptoms relief with Dymista®
Further Your Understanding
Click on one of the below links to discover more information about Dymista®, including Flow to use Dymista®, guidelines, clinical papers and request materials.
Impact of Rhinitis
- Scadding GK, el al. BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017, First edition 2007). Clin Exp Allergy 2017; 47(7): 856-889.
- Lipworth B, et al. An algorithm recommendation for the pharmacological management of allergic rhinitis in the UK: a consensus statement from an expert panel. NPJ Prim Care Respir Med. 2017; 27(1)